A study published in the Journal of the American Medical Association by Belgium researchers comparing the Moderna and Pfizer-BioNTech Covid-19 vaccines found that the Moderna jabs generated twice the antibodies as the Pfizer-BioNTech vaccine.

A pair of the U.S. Food and Drug Administration’s top vaccine experts are leaving the regulatory agency.

Roche

Roche Holding AG decided to withdraw the company’s immunotherapy Tecentriq as a treatment for a type of breast cancer in the United States, the drugmaker said on Aug. 26 following a consultation with the Food and Drug Administration.

The U.S. Food and Drug Administration approved Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd) for children 1 year and older who have growth failure from inadequate secretion of endogenous growth hormone (GH).

AstraZeneca

AstraZeneca said on Aug. 26 a late-stage trial showed the company’s medicine for a rare disease that causes accumulation of copper in the body was three times more successful in helping remove deposits from tissues compared with standard care.

U.S. health regulators could approve a third Covid-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Aug. 25.

The Centers for Disease Control and Prevention (CDC) released a report showing that unvaccinated people are 29 times more likely to be hospitalized with Covid-19 than those who are fully vaccinated against the disease.

Moderna COVID vaccine

Moderna Inc. completed the real-time review process needed for a full approval for the company’s Covid-19 vaccine in people aged 18 years and older.

Formal U.S approval of the Pfizer Inc./BioNTech SE Covid-19 vaccine will make it nearly impossible to successfully challenge mandates by employers, legal experts said.

The United States could get Covid-19 under control by early 2022, with potential wider vaccine approvals coming in the weeks ahead, Dr. Anthony Fauci said one day after Pfizer won wider FDA approval for the company’s novel coronavirus shot on Aug. 23.